Also worth noting that Brandon Capital Partners own 44.1% of the CDI's on issue. Some info about them from their website: "Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients". I am unsure what their percentage will be after the release of the new CDI's, however they are long haul investors that will not be selling anytime soon. An investment this size shows serious conviction.
OSP Price at posting:
1.9¢ Sentiment: Buy Disclosure: Held